Quadrant Capital Group’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3,721
| Closed | -$29.2K | – | 2306 |
|
|
2025
Q1 | $29.2K | Buy |
3,721
+3,643
| +4,671% | +$28.6K | ﹤0.01% | 1911 |
|
|
2024
Q4 | $1.16K | Sell |
78
-57
| -42% | -$849 | ﹤0.01% | 2575 |
|
|
2024
Q3 | $2.07K | Sell |
135
-13
| -9% | -$199 | ﹤0.01% | 2494 |
|
|
2024
Q2 | $2.26K | Sell |
148
-5
| -3% | -$76 | ﹤0.01% | 2455 |
|
|
2024
Q1 | $2.89K | Sell |
153
-288
| -65% | -$5.44K | ﹤0.01% | 2434 |
|
|
2023
Q4 | $8.42K | Sell |
441
-181
| -29% | -$3.46K | ﹤0.01% | 2129 |
|
|
2023
Q3 | $11.2K | Buy |
622
+53
| +9% | +$951 | ﹤0.01% | 1943 |
|
|
2023
Q2 | $11.6K | Buy |
569
+300
| +112% | +$6.09K | ﹤0.01% | 1940 |
|
|
2023
Q1 | $4.91K | Sell |
269
-86
| -24% | -$1.57K | ﹤0.01% | 2243 |
|
|
2022
Q4 | $7.34K | Buy |
355
+114
| +47% | +$2.36K | ﹤0.01% | 2092 |
|
|
2022
Q3 | $6K | Buy |
241
+223
| +1,239% | +$5.55K | ﹤0.01% | 2089 |
|
|
2022
Q2 | $0 | Buy |
+18
| New | – | ﹤0.01% | 2693 |
|